Clinical Trial Update: A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days. [Phase 2]

View source ↗

Summary

A Phase 2 study comparing GW274150 to prednisolone in rheumatoid arthritis, given repeatedly for 28 days. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• GW274150
• Prednisolone (Prednisolone)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED